Literature DB >> 6334374

Morphologic characteristics of posterior polymorphous dystrophy. A study of nine corneas and review of the literature.

A S Henriquez, K R Kenyon, C H Dohlman, S A Boruchoff, S L Forstot, R F Meyer, L A Hanninen.   

Abstract

Based on their own study of nine corneas with clinically documented posterior polymorphous dystrophy and a review of the literature, the authors describe the morphologic features of this entity. Study by phase contrast light microscopy and transmission and scanning electron microscopy found that changes were primarily in the endothelium and consisted of endothelial cell degeneration and loss with focal fibroblastic and epithelial-like cell transformation. Secondary alterations of Descemet's membrane were seen; they consisted of abnormal lamination with deposition of abnormal collagen material, particularly in the posterior collagen layer, and formation of guttate excrescences and pits.

Entities:  

Mesh:

Year:  1984        PMID: 6334374     DOI: 10.1016/0039-6257(84)90171-1

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  14 in total

Review 1.  Biomechanical relationships between the corneal endothelium and Descemet's membrane.

Authors:  Maryam Ali; VijayKrishna Raghunathan; Jennifer Y Li; Christopher J Murphy; Sara M Thomasy
Journal:  Exp Eye Res       Date:  2016-09-14       Impact factor: 3.467

Review 2.  Molecular bases of corneal endothelial dystrophies.

Authors:  Thore Schmedt; Mariana Mazzini Silva; Alireza Ziaei; Ula Jurkunas
Journal:  Exp Eye Res       Date:  2011-08-10       Impact factor: 3.467

3.  In vivo confocal microscopic observations of eyes diagnosed with posterior corneal vesicles.

Authors:  Atsushi Shiraishi; Xiaodong Zheng; Yuri Sakane; Yuko Hara; Yasuhito Hayashi
Journal:  Jpn J Ophthalmol       Date:  2016-09-01       Impact factor: 2.447

4.  A clinicopathologic study of posterior polymorphous dystrophy:implications for pathogenetic mechanism of the associated glaucoma.

Authors:  A B Threlkeld; W R Green; H A Quigley; Z de la Cruz; W J Stark
Journal:  Trans Am Ophthalmol Soc       Date:  1994

5.  Posterior polymorphous corneal dystrophy: a disease characterized by epithelial-like endothelial cells which influence management and prognosis.

Authors:  J H Krachmer
Journal:  Trans Am Ophthalmol Soc       Date:  1985

6.  Novel mutations in the ZEB1 gene identified in Czech and British patients with posterior polymorphous corneal dystrophy.

Authors:  Petra Liskova; Stephen J Tuft; Rhian Gwilliam; Neil D Ebenezer; Katerina Jirsova; Quincy Prescott; Radka Martincova; Marike Pretorius; Neil Sinclair; David L Boase; Margaret J Jeffrey; Panos Deloukas; Alison J Hardcastle; Martin Filipec; Shomi S Bhattacharya
Journal:  Hum Mutat       Date:  2007-06       Impact factor: 4.878

7.  Phenotypic characterisation and ZEB1 mutational analysis in posterior polymorphous corneal dystrophy in a New Zealand population.

Authors:  Andrea L Vincent; Rachael L Niederer; Amanda Richards; Betina Karolyi; Dipika V Patel; Charles N J McGhee
Journal:  Mol Vis       Date:  2009-12-03       Impact factor: 2.367

Review 8.  Characteristics of corneal dystrophies: a review from clinical, histological and genetic perspectives.

Authors:  Ze-Nan Lin; Jie Chen; Hong-Ping Cui
Journal:  Int J Ophthalmol       Date:  2016-06-18       Impact factor: 1.779

9.  Active transforming growth factor-β2 in the aqueous humor of posterior polymorphous corneal dystrophy patients.

Authors:  Andrea Stadnikova; Lubica Dudakova; Pavlina Skalicka; Zdenek Valenta; Martin Filipec; Katerina Jirsova
Journal:  PLoS One       Date:  2017-04-17       Impact factor: 3.240

10.  High prevalence of posterior polymorphous corneal dystrophy in the Czech Republic; linkage disequilibrium mapping and dating an ancestral mutation.

Authors:  Petra Liskova; Rhian Gwilliam; Martin Filipec; Katerina Jirsova; Stanislava Reinstein Merjava; Panos Deloukas; Tom R Webb; Shomi S Bhattacharya; Neil D Ebenezer; Alex G Morris; Alison J Hardcastle
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.